Literature DB >> 21325032

Screening breast MR imaging in women with a history of chest irradiation.

Janice S Sung1, Carol H Lee, Elizabeth A Morris, Kevin C Oeffinger, D David Dershaw.   

Abstract

PURPOSE: To assess the utility of screening magnetic resonance (MR) imaging in detecting otherwise occult breast cancers in women with a history of radiation therapy to the chest.
MATERIALS AND METHODS: This HIPAA-compliant study was approved by the authors' institutional review board. The need for informed consent was waived. Retrospective review of the radiology department database identified 247 screening breast MR imaging examinations performed between January 1999 and December 2008 in 91 women with a history of chest irradiation. Findings and recommendations for each breast MR study and on the most recent mammogram were reviewed. The number of cancers diagnosed, their method of detection, and tumor characteristics were examined. The exact 95% binomial proportion confidence intervals were calculated by using methods described by Clopper and Pearson.
RESULTS: Biopsy was recommended for 32 suspicious lesions on 27 (11%) of 247 MR imaging studies in 21 women. Seven cancers were identified in 30 lesions sampled (23%). Biopsy was recommended in five additional patients on the basis of mammographic findings, and malignancy was detected in three. Ten cancers were detected during the study period: four detected with MR imaging alone, three with MR imaging and mammography, and three with mammography alone. The four cancers detected with MR imaging alone were invasive carcinomas. Two of three cancers detected with mammography alone were ductal carcinoma in situ (DCIS), and the third was DCIS with microinvasion.
CONCLUSION: MR imaging is a useful adjunct modality to screen high-risk women with a history of chest irradiation, resulting in a 4.4% (95% confidence interval: 1.2%, 10.9%) incremental cancer detection rate; the sensitivity for detecting breast cancers by using a combination of MR imaging and mammography was higher than that for either modality alone. © RSNA, 2011.

Entities:  

Mesh:

Year:  2011        PMID: 21325032     DOI: 10.1148/radiol.10100991

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI.

Authors:  Valencia King; Yajia Gu; Jennifer B Kaplan; Jennifer D Brooks; Malcolm C Pike; Elizabeth A Morris
Journal:  Eur Radiol       Date:  2012-07-04       Impact factor: 5.315

2.  Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.

Authors:  Anna M Chiarelli; Kristina M Blackmore; Derek Muradali; Susan J Done; Vicky Majpruz; Ashini Weerasinghe; Lucia Mirea; Andrea Eisen; Linda Rabeneck; Ellen Warner
Journal:  J Natl Cancer Inst       Date:  2020-02-01       Impact factor: 13.506

3.  Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.

Authors:  Kathleen C Horst; Katherine E Fero; Steven L Hancock; Ranjana H Advani; Debra M Ikeda; Bruce Daniel; Saul A Rosenberg; Sarah S Donaldson; Richard T Hoppe
Journal:  Am J Clin Oncol       Date:  2016-04       Impact factor: 2.339

4.  Mammography and MRI for screening women who underwent chest radiation therapy (lymphoma survivors): recommendations for surveillance from the Italian College of Breast Radiologists by SIRM.

Authors:  Giovanna Mariscotti; Paolo Belli; Daniela Bernardi; Beniamino Brancato; Massimo Calabrese; Luca A Carbonaro; Beatrice Cavallo-Marincola; Francesca Caumo; Paola Clauser; Laura Martinchich; Stefania Montemezzi; Pietro Panizza; Federica Pediconi; Alberto Tagliafico; Rubina M Trimboli; Chiara Zuiani; Francesco Sardanelli
Journal:  Radiol Med       Date:  2016-07-12       Impact factor: 3.469

5.  Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group.

Authors:  Renée L Mulder; Melissa M Hudson; Smita Bhatia; Wendy Landier; Gill Levitt; Louis S Constine; W Hamish Wallace; Flora E van Leeuwen; Cécile M Ronckers; Tara O Henderson; Chaya S Moskowitz; Danielle N Friedman; Andrea K Ng; Helen C Jenkinson; Charlotte Demoor-Goldschmidt; Roderick Skinner; Leontien C M Kremer; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2020-09-29       Impact factor: 44.544

6.  Microcalcification detectability using a bench-top prototype photon-counting breast CT based on a Si strip detector.

Authors:  Hyo-Min Cho; Huanjun Ding; William C Barber; Jan S Iwanczyk; Sabee Molloi
Journal:  Med Phys       Date:  2015-07       Impact factor: 4.071

Review 7.  Breast cancer screening for women at high risk: review of current guidelines from leading specialty societies.

Authors:  Natsuko Onishi; Masako Kataoka
Journal:  Breast Cancer       Date:  2020-09-21       Impact factor: 4.239

8.  Diffusion-Weighted MRI of the Breast in Women with a History of Mantle Radiation: Does Radiation Alter Apparent Diffusion Coefficient?

Authors:  Punam Bajaj; Chiara Iacconi; David D Dershaw; Elizabeth A Morris
Journal:  J Breast Imaging       Date:  2019-08-29

Review 9.  Breast MRI: EUSOBI recommendations for women's information.

Authors:  Ritse M Mann; Corinne Balleyguier; Pascal A Baltzer; Ulrich Bick; Catherine Colin; Eleanor Cornford; Andrew Evans; Eva Fallenberg; Gabor Forrai; Michael H Fuchsjäger; Fiona J Gilbert; Thomas H Helbich; Sylvia H Heywang-Köbrunner; Julia Camps-Herrero; Christiane K Kuhl; Laura Martincich; Federica Pediconi; Pietro Panizza; Luis J Pina; Ruud M Pijnappel; Katja Pinker-Domenig; Per Skaane; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2015-05-23       Impact factor: 5.315

10.  [Malignant phyllodes tumor of the breast after Hodgkin's disease].

Authors:  El Hfid Mohamed; Mezouar Loubna; El Harroudi Tijani
Journal:  Pan Afr Med J       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.